According to Akoya Biosciences's latest financial reports the company has $83.12 M in cash and cash equivalents.
A companyโs cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Year | Cash on Hand | Change |
---|---|---|
2023-12-31 | $83.12 M | 2.35% |
2022-12-31 | $81.21 M | -28.18% |
2021-12-31 | $0.11 B | 564.94% |
2020-12-31 | $17 M | -21.48% |
2019-12-31 | $21.65 M |